Rituximab (RTX) plus Methotrexate (MTX) prevents bone erosion and joint-space narrowing (JSN) and reduces synovitis, osteitis as shown on MRI: Results from a randomised, placebo-controlled trial in patients (PTS) with rheumatoid arthritis (RA-score)

Publication | Closed Access

Citations

References

2011

Year

Charles Peterfy, Paul Emery, P. P. Tak, Mikkel Østergaard, Julie C. DiCarlo, Kati Otsa, Federico Navarro Sarabia, Karel Pavelká, Kenzie L. Preston, T. Shaw,

Annals of the Rheumatic Diseases